Ocugen (OCGN) filed a registration statement Friday for the sale of up to 57.5 million shares by selling stockholders.
The prospectus includes 56.5 million common shares issuable on conversion of notes for up to $6 million outstanding principal amount of notes and 1.1 million shares issued to lenders in a private placement, the company added.
Ocugen said it will not receive any proceeds from the sale of shares by selling stockholders.
Shares were up nearly 2% in recent after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.